Concepedia

Huadan Xu

HX

Statistics

Publications

8

Citations

274

H-Index

8

Active since

2017

Affiliations

Jilin University(Current)

Jilin Medical University

First Hospital of Jilin University

Union Hospital

Tianjin University

Huadan Xu is an author at Jilin University specializing in oncology, pharmacology, and medicine.

ORCID

Publications per year

2017–2023

8

Publications

8

Dicumarol inhibits PDK1 and targets multiple malignant behaviors of ovarian cancer cells

Wenjia Zhang, Jing Su, Huadan Xu et al. · PLoS ONE · 2017 · 99 citations · Full text

, , +16

The IL-33/ST2 axis affects tumor growth by regulating mitophagy in macrophages and reprogramming their polarization

Huadan Xu, Dong Li, Jiaoyan Ma et al. · Cancer Biology and Medicine · 2021 · 46 citations · Full text

, , +17

Deficiency in IL-33/ST2 Axis Reshapes Mitochondrial Metabolism in Lipopolysaccharide-Stimulated Macrophages

Huadan Xu, Liankun Sun, Yichun He et al. · Frontiers in Immunology · 2019 · 39 citations · Full text

, , +16

Bridge evolution during the coalescence of immiscible droplets

Huadan Xu, Tianyou Wang, Zhizhao Che · Journal of Colloid and Interface Science · 2022 · 29 citations · Full text

, , +12

PGC1α promotes cisplatin resistance in human ovarian carcinoma cells through upregulation of mitochondrial biogenesis

Luyan Shen, Boyang Sun, Jiyao Sheng et al. · International Journal of Oncology · 2018 · 21 citations · Full text

, , +16

1–5 of 8